other material
confidence high
sentiment neutral
materiality 0.75
Vaxcyte prices $650.7M underwritten public offering of common stock and pre-funded warrants
Vaxcyte, Inc.
- Selling 15M shares at $32.00/share and pre-funded warrants for 3.75M shares at $31.999 each.
- Underwriters exercised option to purchase additional 2,812,500 shares; net proceeds expected ~$650.7M.
- Closing expected October 28, 2022, subject to customary closing conditions.
- Underwriting agreement filed as Exhibit 1.1; pre-funded warrant form filed as Exhibit 4.1.